The global market for structural heart devices is expected to reach $22.16 billion by 2029, growing from $13.75 billion in 2023. This growth represents a compound annual growth rate (CAGR) of 8.28% from 2024 to 2029, according to a report by ResearchAndMarkets.com.
The increase in market size is largely driven by the rising prevalence of cardiovascular diseases (CVD) and metabolic disorders, especially in developing countries. Structural heart devices are essential for diagnosing and treating abnormalities in the heart’s structure, including heart valve diseases and congenital defects.
Factors contributing to this growth include higher rates of coronary artery disease, heart failure, and chronic kidney disease.
Additionally, an aging population, increasing congenital heart disorders among infants, and rising risk factors such as obesity and hypertension are fueling demand for these devices. Modern lifestyle choices—like sedentary behavior, poor diet, and stress—are also linked to the growing incidence of heart-related health issues.
As the prevalence of CVD continues to rise globally, the structural heart devices market is poised for significant expansion in the coming years.
Related topics:
- UVA Health Introduces Innovative Method for Heart Valve Replacement
- American Heart Association Launches $75 Million Fund to Support Women’s Health Initiatives
- American Heart Association Hosts 2024 Montgomery County Heart Walk in The Woodlands